AzTrials
AzTrials

CataractNCT06364761

Assesment of Intermediate Vision After BIL Cataract Surgery

An observational study of Cataract, run by Universitair Ziekenhuis Brussel.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The goal of this observational study is to learn about the intermediate and near vision in patiënts who underwent cataract surgery with a specific technique, called "bag in the lens". Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Cataract
What is being tested?
Bag in the lens cataract surgery
Type of treatment
Surgery or procedure
How many people
38 participants
Where
No sites listed yet
Study dates
Apr 2024to Dec 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Patients who underwent bilateral bag in the lens cataract surgery in the University Hospital Brussels at least 3 months before inclusion

Who may be able to join

  • Patients of at least 18 years old
  • Must have underwent bilateral bag in the lens cataract surgery in the University hospital Brussels at least 3 months before inclusion
  • Must not meet any exclusion criteria

Who cannot join

  • Prior refractive surgery (other than bag in the lens)
  • Glaucoma
  • Corneal opacities
  • Moderate non proliferative diabetic retinopathy or worse
  • Optic neuropathy
  • History of uveitis
Show all 10Show fewer
  • Amblyopia
  • Residual post-operative astigmatism higher than 1.5 Diopters (D)
  • Best corrected visual acuity < 1.0
  • Patients unable to cooperate or sign the informed consent

Trial locations and contacts

No sites are listed yet.

Jorgos Koulalis, M.D. contact

+32474045858

jorkoul@hotmail.com

About this study

Official title: Assesment of Intermediate and Near Vision After Bag in the Lens Cataract Surgery

The goal of this observational study is to learn about the intermediate and near vision in patiënts who underwent cataract surgery with a specific technique, called "bag in the lens".

The main question it aims to answer is whether patiens who underwent this type of cataract surgery have better intermediate vision without spectacle correction than patients who underwent the classic lens in the bag cataract surgery.

Read more

Participants will:

  • Have to read with and without spectacle correction at different distances (4 meters, 66 centimeters, 40 centimeters)
  • Have to fill in 2 questionnaires about visual functioning and spectacle independance

Researchers will compare these values to the same values from the standard population who underwent the classic lens in the bag cataract surgery with a monofocal intraocular lens .

Conditions
Cataract
Being tested
Bag in the lens cataract surgery
Keywords
bag in lens, Intermediate vision
Medical subject headings
Cataract

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Bag in the lens cataract surgeryProcedure or surgery

    Cataract surgery using the Morcher 89A intraocular lens

Study groups in NCT06364761
Study groupRoleWhat they receive
Bag in the lensPatients who underwent bag in the lens cataract surgery at least 3 months before inclusion in the University Hospital Brussels, Belgium.
Receives: Procedure: Bag in the lens cataract surgery

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Intermediate vision

    uncorrected and distance corrected intermediate vision at 66cm in LogMAR

    Measured: During the only hospital visit required in the study, between april and december 2024

Secondary outcomes (1)
  1. Near vision

    uncorrected and distance corrected intermediate vision at 40cm in LogMAR

    Measured: During the only hospital visit required in the study, between april and december 2024

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Apr 2024
  2. Study startApr 2024 (estimated)
  3. Primary completionDec 2024 (estimated)
  4. Study completionDec 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Cross-sectional
Enrolment
38 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06364761
Sponsor's protocol ID
24103_BIL_EDOF
Status last verified
Mar 2024
First submitted
9 Apr 2024
Last updated
15 Apr 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Cataract, run by Universitair Ziekenhuis Brussel.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 15 Apr 2024. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Jorgos Koulalis, M.D. (+32474045858, jorkoul@hotmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Intermediate vision (time frame: During the only hospital visit required in the study, between april and december 2024). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Apr 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in